News
Beyond the hype, what does AI really mean for doctors and patients? Let's look at the promise, the problems, and the ...
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for GTx-104 for the treatment of aneurysmal subarachnoid hemorrhage (aSAH).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback